People

Imran Babar

Imran Babar serves as Chief Business & Financial Officer at Sudo Biosciences. Business and finance executive with prior roles at the orphan drug accelerator Cydan II and OrbiMed; co-founded Arvada Therapeutics and serves on the Rare Genomics Institute board.